Pharmaceuticals

Healthcare

16 July, 2014

Sun Pharma acquires Pharmalucence

Sun Pharmaceutical Industries Ltd, India’s largest pharmaceutical company by market capitalisation, has revived its overseas acquisition activity by snapping US-based ......

Healthcare

21 July, 2014

Sun Pharma-Ranbaxy deal gets BSE, NSE clearance

The USD 4-billion merger of Ranbaxy Labs with Sun Pharmaceutical has got clearance from the two leading stock exchanges -- ......

Healthcare

15 July, 2014

Glenmark gets USFDA approval for skin infection cream

Mumbai-based Glenmark Pharmaceutical Limited, which focuses on research to develop new chemical entities (NCEs) and new biological entities (NBEs), has ......

Healthcare

14 July, 2014

GVK Biosciences acquires remaining 6.12% stake in Inogent from Dai-ichi Karkaria

Contract research firm GVK Biosciences Pvt Ltd, which operates under the GVK BIO brand, has acquired the remaining 6.12 per ......

Healthcare

14 July, 2014

Indian drug regulator puts price ceiling on 108 diabetes, cardiac formulations

In a move that is likely to bring down prices of some of the key medicines, drug pricing regulator NPPA ......

Healthcare

09 July, 2014

Cipla to invest around $171M in UK arm

Mumbai-based drugmaker Cipla Ltd plans to invest up to £100 million (around $171 million) in its UK-based subsidiary in the ......

Healthcare

07 July, 2014

Lupin to set up two new R&D centres in US

Pharma major Lupin said it is in the process of setting up two new R&D centres in the US, focusing ......

Premium

Healthcare

01 July, 2014

Deal of the month: Japan's Meiji buying Temasek-backed drugmaker Medreich

Deal: Meiji Seika Pharma, a part of Meiji Holdings Co. Ltd, is acquiring Temasek-backed drugmaker Medreich Ltd, a Bangalore-based contract ......

Healthcare

30 June, 2014

Cipla to acquire majority stake in UAE-based pharma manufacturer for $21M

Mumbai-based drugmaker Cipla Ltd is acquiring 51 per cent stake in a UAE-based pharmaceutical company which has manufacturing and distribution ......

Healthcare

27 June, 2014

Ranbaxy gets US FDA approval to sell generic version of Novartis' heart drug

Daiichi Sankyo-controlled Indian drug major Ranbaxy Laboratories Ltd has received first-to-file US Food and Drug Administration (FDA) approval, with 180-day ......